As of 2025-01-24, the Relative Valuation of FibroGen Inc (FGEN) is (32.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.51 USD, the upside of FibroGen Inc based on Relative Valuation is -6582.4%.
The range of the Relative Valuation is (33.53) - (33.74) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.7x - 40.5x | 35.3x |
| Forward P/E multiples | 18.8x - 27.9x | 19.0x |
| Fair Price | (33.53) - (33.74) | (32.81) |
| Upside | -6723.3% - -6766.3% | -6582.4% |
| Date | P/E |
| 2025-01-17 | -0.47 |
| 2025-01-16 | -0.48 |
| 2025-01-15 | -0.50 |
| 2025-01-14 | -0.46 |
| 2025-01-13 | -0.49 |
| 2025-01-10 | -0.51 |
| 2025-01-08 | -0.54 |
| 2025-01-07 | -0.52 |
| 2025-01-06 | -0.55 |
| 2025-01-03 | -0.45 |
| 2025-01-02 | -0.44 |
| 2024-12-31 | -0.44 |
| 2024-12-30 | -0.44 |
| 2024-12-27 | -0.48 |
| 2024-12-26 | -0.48 |
| 2024-12-24 | -0.41 |
| 2024-12-23 | -0.40 |
| 2024-12-20 | -0.33 |
| 2024-12-19 | -0.29 |
| 2024-12-18 | -0.28 |
| 2024-12-17 | -0.29 |
| 2024-12-16 | -0.27 |
| 2024-12-13 | -0.28 |
| 2024-12-12 | -0.28 |
| 2024-12-11 | -0.29 |
| 2024-12-10 | -0.30 |
| 2024-12-09 | -0.30 |
| 2024-12-06 | -0.28 |
| 2024-12-05 | -0.34 |
| 2024-12-04 | -0.34 |
| 2024-12-03 | -0.34 |
| 2024-12-02 | -0.35 |
| 2024-11-29 | -0.35 |
| 2024-11-27 | -0.32 |
| 2024-11-26 | -0.32 |
| 2024-11-25 | -0.32 |
| 2024-11-22 | -0.33 |
| 2024-11-21 | -0.32 |
| 2024-11-20 | -0.29 |
| 2024-11-19 | -0.29 |
| 2024-11-18 | -0.28 |
| 2024-11-15 | -0.28 |
| 2024-11-14 | -0.31 |
| 2024-11-13 | -0.27 |
| 2024-11-12 | -0.32 |
| 2024-11-11 | -0.28 |
| 2024-11-08 | -0.27 |
| 2024-11-07 | -0.26 |
| 2024-11-06 | -0.26 |
| 2024-11-05 | -0.25 |